{"text": "TITLE:\n      Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes\nSUMMARY:\n      This trial is conducted in the United States of America (USA). This trial aims for a\n      comparison of the safety and efficacy in subjects with type 2 diabetes using either self\n      titration or physician guided titration according to the local standard of care.\nELIGIBILITY CRITERIA:\n      Inclusion Criteria:\n          -  Diagnosis of type 2 diabetes HbA1C <= 12.0% within the past 12 months;\n          -  BMI <= 45.0 kg/m2\n          -  Initiation, addition of, change to, or continuation of basal insulin therapy with\n             insulin detemir as deemed necessary by Investigator\n        Exclusion Criteria:\n          -  Anticipated change in concomitant medication known to interfere with glucose\n             metabolism such as systemic steroids, non-selective beta-blockers or mono amine\n             oxidase (MAO) inhibitors.\n          -  Proliferative retinopathy or maculopathy that has required acute treatment within the\n             last 6 months.\n          -  Any glucose lowering medication that is not indicated in combination with insulin,\n             such as GLP-1 Analogues\n          -  Known hypoglycemia unawareness or recurrent major hypoglycemia, as judged by the\n             Investigator\n", "cuis": "C2936643 C0011860 C0087111 C1533734 C3887704 C0746919 C2945673 C1552616 C1706244 C0018792 C1277469 C0011860 C1320657 C1551994 C2936643 C0162621 C0804815 C0243161 C0013893 C0243161 C0011860 C1320657 C0011900 C0945731 C0373638 C1561542 C0589507 C0021641 C3537244 C0087111 C0033972 C0457454 C1444662 C0537270 C3899561 C0243161 C3840775 C0013227 C2081612 C2094204 C0033045 C1971835 C0802604 C2598133 C0017725 C3845898 C0025519 C3822292 C0001645 C0722436 C0339467 C0339473 C2187289 C0035320 C0154837 C0730362 C0015397 C0087111 C3887704 C0376495 C1533734 C0746919 C0814472 C3647788 C3245501 C3245502 C1619636 C1561542 C0013227 C2081612 C2094204 C0033045 C1971835 C0802604 C2598133 C0017725 C0021641 C3537244 C3539181 C3539182 C3539954 C3539955 C3539956 C3539957 C3539959 C3539960 C3539961 C3539962 C3539963 C3539964 C3539965 C3539966 C3539967 C3539968 C3539969 C3539970 C3539971 C3539972 C3539973 C3539974 C3539975 C3539976 C3539977 C3539978 C3539979 C3540026 C3540027 C3540028 C3540030 C3540031 C3540719 C3540720 C3540721 C3540722 C3540723 C3540724 C3540740 C3854036 C3811910 C0052142 C0251244 C0965970 C1820370 C1444655 C0020615 C0020616 C0041657 C0589402 C0004448 C3899561 ", "concepts": "Standard of Care, Type 2 Diabetes, treatment, Treatment, treatment, No Treatment, adjustments summary, summary Atrial, Born in United States of America type 2 diabetes, type diabetes, self standard of care, titration, Physician criteria, Eligibility Criteria type 2 diabetes, type diabetes, {Diagnosis}, Diagnosis, HbA1C, month Initiation, insulin, Insulins, therapy, Cotherapy, discontinuations, Discontinuation insulin detemir, Investigator CVs Criteria Anticipated, Medications, medication:, medications:, Premedication, IV medication, Medications, Medications, glucose, Uknown metabolism, H2 metabolism, beta-blocker, Pamine Proliferative retinopathy NOS, Preproliferative retinopathy, nonproliferative retinopathy, Vasoproliferative retinopathy, Other proliferative retinopathy, maculopathy, oculopathy, Treatment, treatment, Retreatment, Treatment, no treatment, co-treatment, maltreatment, required, required, Required month Medications, medication:, medications:, Premedication, IV medication, Medications, Medications, glucose, insulin, Insulins, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, combinations, Combination, AP combination, MP combination, ET combination, flowering, Not indicated hypoglycemia nos, hypoglycemic, unawareness, unawareness, awareness Investigator CVs "}
